Air pollution fuels lung cancer in non-smokers, study

Air Pollution could drive lung cancer mutations in people with little to no history of smoking
Air Pollution could drive lung cancer mutations in people with little to no history of smoking

A new study published in Nature says air pollution may be driving lung cancer development in people who have little to no history of smoking.

Exposure to air pollution, other contaminants, and even traditional herbal medicines can contribute to the same genetic mutations that occur in smokers. Lung cancer in never smokers accounts for roughly a quarter of all lung cancer cases.

“We’re seeing this problematic trend that never-smokers are increasingly getting lung cancer, but we haven’t understood why,” said co-senior author Ludmil Alexandrov, a professor of bioengineering and cellular and molecular medicine at the University of California, San Diego, in a statement, per The Hill.

While tobacco use has fallen significantly in parts of the world, lung cancer in never smokers is trending upwards as a proportion of all lung cancer cases. In particular, say the researchers, the phenomenon is more pronounced in women of Asian ancestry, and the rate is higher in East Asian countries.

The researchers examined lung tumors from 871 never-smokers from 28 regions around the world. Specific patterns of DNA mutations, or “mutational signatures,” were identified, serving as a clue to past exposures that drove DNA changes. Using these findings, combined with satellite and ground-level pollution measurements of fine particulate matter, the researchers were able to estimate each participant’s long-term exposure levels.

Never-smokers who resided in more polluted places were found to have far more mutations in their lung tumors, especially those that can lead to the development of cancer. The people living in the more polluted regions had a nearly fourfold jump in mutational signature that is more often associated with smoking.

Related
Read more : Health

FDA approves Kerendia for cardiac failure with LVEF ≥40 percent

FDA approves Kerendia for cardiac failure with LVEF ≥40 percent
Kerendia, a nonsteroidal mineralocorticoid receptor antagonist that inhibits overactivation of mineralocorticoid receptors

Measles outbreak: Alberta exceeds case counts reported across US

Measles outbreak: Alberta exceeds case counts reported across US
Alberta reports 1,314 cases since March, surpassing the United States in confirmed measles cases

Cancer patients given new hope as NHS chief declares major progress

Cancer patients given new hope as NHS chief declares major progress
A senior NHS official has shared a message of hope for those facing a cancer diagnosis

Top home remedies to beat dandruff in 2025

Top home remedies to beat dandruff in 2025
Discover a few effective ways to naturally reduce dandruff at home

Untreated high cholesterol may lead to needless cardiac events: Study

Untreated high cholesterol may lead to needless cardiac events: Study
Results indicated that among participants who had never suffered a cardiac attack or stroke, 47% of them were eligible for statins

Measles outbreak in Liverpool: child passes away as cases surge

Measles outbreak in Liverpool: child passes away as cases surge
Alder Hey Children's Hospital has issued a warning regarding measles, as they continue to rise in the UK

Boost your brain with this everyday kitchen ingredient, says study

Boost your brain with this everyday kitchen ingredient, says study
Approximately 55 million people worldwide are currently living with dementia, a general term for loss of memory and other thinking abilities

US cuts to HIV aid may lead to 4 million deaths by 2029, UN warns

US cuts to HIV aid may lead to 4 million deaths by 2029, UN warns
Experts cautioned that the US is 'abandoning the fight' just as ending AIDS is within reach